CIMINO, Luca
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 12.977
AS - Asia 7.191
EU - Europa 4.577
SA - Sud America 1.688
AF - Africa 208
OC - Oceania 41
Continente sconosciuto - Info sul continente non disponibili 7
Totale 26.689
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 12.613
SG - Singapore 2.047
CN - Cina 1.538
HK - Hong Kong 1.388
BR - Brasile 1.289
GB - Regno Unito 1.031
IT - Italia 987
VN - Vietnam 864
FI - Finlandia 601
SE - Svezia 490
BD - Bangladesh 329
RU - Federazione Russa 303
DE - Germania 295
CA - Canada 233
KR - Corea 205
FR - Francia 170
BG - Bulgaria 159
IN - India 158
AR - Argentina 135
NL - Olanda 130
UA - Ucraina 124
ID - Indonesia 118
TR - Turchia 113
JP - Giappone 85
EC - Ecuador 68
IQ - Iraq 68
EG - Egitto 61
MX - Messico 53
AT - Austria 49
ES - Italia 48
ZA - Sudafrica 46
CL - Cile 43
CO - Colombia 43
PL - Polonia 40
PE - Perù 37
AU - Australia 31
AE - Emirati Arabi Uniti 29
PK - Pakistan 28
IE - Irlanda 27
MY - Malesia 27
VE - Venezuela 26
MA - Marocco 25
PY - Paraguay 22
CZ - Repubblica Ceca 21
UZ - Uzbekistan 21
IL - Israele 18
SA - Arabia Saudita 18
UY - Uruguay 18
KW - Kuwait 17
BZ - Belize 16
DZ - Algeria 16
KE - Kenya 16
LT - Lituania 15
NP - Nepal 14
TN - Tunisia 14
TH - Thailandia 13
AL - Albania 12
BE - Belgio 10
GT - Guatemala 10
PH - Filippine 10
TW - Taiwan 10
PT - Portogallo 9
CH - Svizzera 8
DO - Repubblica Dominicana 8
IR - Iran 8
JM - Giamaica 8
KZ - Kazakistan 8
RO - Romania 8
AZ - Azerbaigian 7
DK - Danimarca 7
JO - Giordania 7
SI - Slovenia 7
TT - Trinidad e Tobago 7
BO - Bolivia 6
CR - Costa Rica 6
MN - Mongolia 6
NZ - Nuova Zelanda 6
PA - Panama 6
PR - Porto Rico 6
CY - Cipro 5
EU - Europa 5
KG - Kirghizistan 5
OM - Oman 5
ET - Etiopia 4
MK - Macedonia 4
NO - Norvegia 4
AO - Angola 3
BH - Bahrain 3
GE - Georgia 3
HN - Honduras 3
HU - Ungheria 3
LB - Libano 3
LV - Lettonia 3
LY - Libia 3
NG - Nigeria 3
RS - Serbia 3
SN - Senegal 3
CI - Costa d'Avorio 2
CV - Capo Verde 2
FJ - Figi 2
Totale 26.644
Salva come PNG Salva come JPEG
Città #
Stanford 1.790
Santa Clara 1.681
Hong Kong 1.371
Ashburn 1.348
Singapore 1.112
Fairfield 906
Helsinki 558
Chandler 459
London 455
Houston 450
Woodbridge 443
San Jose 408
Nyköping 386
Southend 364
Seattle 344
Beijing 328
Ho Chi Minh City 319
Cambridge 299
Wilmington 299
The Dalles 253
Ann Arbor 227
Los Angeles 223
Hefei 213
New York 204
Seoul 201
Hanoi 198
Council Bluffs 178
Princeton 173
Jacksonville 168
Sofia 153
Toronto 150
Modena 149
San Diego 147
Dearborn 139
Dallas 123
Milan 123
São Paulo 109
Buffalo 101
Moscow 101
Chicago 84
Lauterbourg 67
Shanghai 65
Capelle aan den IJssel 63
Jakarta 63
Rome 56
Nuremberg 52
Redondo Beach 50
Tokyo 50
Orem 49
Cairo 42
Frankfurt am Main 41
Rio de Janeiro 41
Columbus 39
Eugene 38
Guangzhou 35
Munich 35
Salt Lake City 35
Haiphong 34
Montreal 31
Da Nang 30
Bologna 27
Izmir 27
Warsaw 26
Lima 25
Phoenix 25
Vienna 25
Amsterdam 24
Brasília 24
Curitiba 24
Dublin 24
Philadelphia 24
Santiago 24
Baghdad 23
Biên Hòa 23
Denver 23
Quito 23
Reggio Emilia 23
Belo Horizonte 22
Porto Alegre 22
Paris 21
Bengaluru 20
Boardman 20
Brooklyn 20
Melbourne 20
Turin 20
Guayaquil 19
Atlanta 18
Johannesburg 18
Kilburn 17
Kuwait City 17
Mexico City 17
Miano 17
Tashkent 17
Belize City 16
Elk Grove Village 16
Kuala Lumpur 16
Palermo 16
Piscataway 16
Florence 15
Mumbai 15
Totale 18.482
Salva come PNG Salva come JPEG
Nome #
Assessment and classification of choroidal vasculitis in posterior uveitis using indocyanine green angiography 865
Sensitivity of indocyanine green angiography for the follow-up of active inflammatory choriocapillaropathies 509
Collaborative Ocular Tuberculosis Study Consensus Guidelines on the Management of Tubercular Uveitis—Report 1: Guidelines for Initiating Antitubercular Therapy in Tubercular Choroiditis 495
Visual loss and other cranial ischaemic complications in giant cell arteritis 345
Assessment of the Anti-inflammatory Effects of NORFLO® ORO in Acute Relapses of HLA-B27-associated Autoimmune Uveitis: A Multicenter, Randomized, Placebo-controlled, Double-blind Clinical Study 317
-463 G/A myeloperoxidase promoter polymorphism in giant cell arteritis 314
Collaborative Ocular Tuberculosis Study Consensus Guidelines on the Management of Tubercular Uveitis—Report 2: Guidelines for Initiating Antitubercular Therapy in Anterior Uveitis, Intermediate Uveitis, Panuveitis, and Retinal Vasculitis 310
G/R 241 polymorphism of intercellular adhesion molecule 1 (ICAM-1) is associated with Fuchs uveitis 293
Correlations between histopathological findings and clinical manifestations in biopsy-proven giant cell arteritis 280
Comparison between colour duplex sonography findings and different histological patterns of temporal artery 279
Acute zonal occult outer retinopathy complex disease: Lessons learned about choroid, photoreceptors, and retinal function 278
Efficacy and safety of adalimumab in Behçet's disease-related uveitis: a multicenter retrospective observational study 272
anti-TNF agents as therapeutic choice in immune-mediated inflammatory diseases: focus on adalimumab 270
Long-term remission in biopsy proven giant cell arteritis: A retrospective cohort study 268
Risk factors for severe cranial ischaemic events in an Italian population-based cohort of patients with giant cell arteritis 265
Interferon Alpha-2a for the Treatment of Post-Infectious Uveitis Secondary to Presumed Intraocular Tuberculosis 265
MicroRNA markers of inflammation and remodelling in temporal arteries from patients with giant cell arteritis 265
Epidemiology and clinical course of Behçet's disease in the Reggio Emilia area of Northern Italy: a seventeen-year population-based study 258
Ophthalmic manifestations of cat scratch disease 258
Is colour duplex sonography-guided temporal artery biopsy useful in the diagnosis of giant cell arteritis? A randomized study 257
Increased expression of interleukin-22 in patients with giant cell arteritis 254
Higher Frequencies of Lymphocytes Expressing the Natural Killer Group 2D Receptor in Patients With Behçet Disease 252
Adalimumab in the treatment of immune-mediated diseases 246
Histopathologic Findings of Patients With Biopsy-Negative Giant Cell Arteritis Compared to Those Without Arteritis: A Population-Based Study 246
Acute-phase reactants during tocilizumab therapy for severe COVID-19 pneumonia 246
The causes of uveitis in a referral centre of Northern Italy 244
Association Between Specimen Length and Number of Sections and Diagnostic Yield of Temporal Artery Biopsy for Giant Cell Arteritis 230
Small-vessel vasculitis surrounding an uninflamed temporal artery and isolated vasa vasorum vasculitis of the temporal artery: two subsets of giant cell arteritis 228
Differential inflammatory involvement in retina and choroid in birdshot chorioretinopathy 227
Risk factors for visual loss in an Italian population-based cohort of patients with giant cell arteritis 224
Effectiveness of Infliximab and Interferon Alpha-2a for the Treatment of Behçet’s Uveitis: Customizing Therapy according to the Clinical Features 220
Choroidal Vascular Changes in Multiple Evanescent White Dot Syndrome 220
Searching for viral antibodies and genome in intraocular fluids of patients with Fuchs uveitis and non-infectious uveitis 219
Tuberculous uveitis, a resurgent and underdiagnosed disease 217
Standardization of red flags for referral to rheumatologists and ophthalmologists in patients with rheumatic diseases and ocular involvement: a consensus statement 216
Adalimumab for prevention of uveitic flare in patients with inactive non-infectious uveitis controlled by corticosteroids (VISUAL II): a multicentre, double-masked, randomised, placebo-controlled phase 3 trial 215
Long-term efficacy of infliximab in refractory posterior uveitis of Behcet's disease: a 24-month follow-up study 214
Multidisciplinary Management of Spondyloarthritis-Related Immune-Mediated Inflammatory Disease 213
PlA1/A2 polymorphism of the platelet glycoprotein receptor IIIA and risk of cranial ischemic complications in giant cell arteritis 210
Ebv-driven lymphoproliferative disorders and lymphomas of the gastrointestinal tract: A spectrum of entities with a common denominator (part 3) 208
Interleukin-10 promoter polymorphisms in giant cell arteritis 205
The role of tumour necrosis factor in the pathogenesis of immune-mediated diseases 203
miR-146a and miR-146b regulate the expression of ICAM-1 in giant cell arteritis 199
Erratum to: Changes in patterns of uveitis at a tertiary referral center in Northern Italy: analysis of 990 consecutive cases (International Ophthalmology, (2017), 10.1007/s10792-016-0434-x) 198
Guidance on Noncorticosteroid Systemic Immunomodulatory Therapy in Noninfectious Uveitis: Fundamentals Of Care for UveitiS (FOCUS) Initiative 195
Quasi cieco all'improvviso 194
Ebv-driven lymphoproliferative disorders and lymphomas of the gastrointestinal tract: A spectrum of entities with a common denominator (part 2) 193
Anterior ischaemic optic neuropathy in eosinophilic granulomatosis with polyangiitis (Churg-Strauss syndrome): a case report and review of the literature 191
Assessment of disease activity in large-vessel vasculitis: Results of an international delphi exercise 191
Flares in Biopsy-Proven Giant Cell Arteritis in Northern Italy: Characteristics and Predictors in a Long-Term Follow-Up Study 190
Cutaneous Involvement in Diseases with Plasma Cell Differentiation: Diagnostic Approach 188
The therapeutic potential of tuftsin-phosphorylcholine in giant cell arteritis 186
Clinical features and outcomes of patients with tubercular uveitis treated with antitubercular therapy in the collaborative ocular tuberculosis study (COTS)-1 185
Reggio Emilia (Northern Italy) Interdisciplinary Uveitis Clinic: What We Have Learned in the Last 20 Years 182
Cytokine Profiling in Aqueous Humor Samples From Patients With Non-Infectious Uveitis Associated With Systemic Inflammatory Diseases 182
Consensus Recommendations for the Diagnosis of Vitreoretinal Lymphoma 181
Diagnosis and Treatment of Listeria monocytogenes Endophthalmitis: A Systematic Review 179
Clinical Features and Prevalence of Spondyloarthritis in a Cohort of Italian Patients Presenting with Acute Nongranulomatous Anterior Uveitis 179
Uveitis and other ocular complications following covid-19 vaccination 171
Scoring of dual fluorescein and ICG inflammatory angiographic signs for the grading of posterior segment inflammation (dual fluorescein and ICG angiographic scoring system for uveitis) 165
Relapses and long-term remission in large vessel giant cell arteritis in northern Italy: Characteristics and predictors in a long-term follow-up study 162
Autoimmune uveitis in children: clinical correlation between antinuclear antibody positivity and ocular recurrences 162
Surgical management of post-uveitic epiretinal membranes 161
Toll-like receptor 4 (TLR4) gene polymorphisms in giant cell arteritis 160
Susceptibility and severity of COVID-19 in patients treated with bDMARDS and tsDMARDs: A population-based study 160
Distribution patterns of 18F-fluorodeoxyglucose in large vessels of Takayasu's and giant cell arteritis using positron emission tomography 158
Aqueous Humor Analysis in Overlapping Clinical Diagnosis of Cytomegalovirus and Rubella Virus Anterior Uveitis 154
Cataract Surgery with Intraocular Lens Implantation in Juvenile Idiopathic Arthritis-Associated Uveitis: Outcomes in the Era of Biological Therapy 150
Abatacept for Severe Anti-Tumor Necrosis Factor alpha Refractory Juvenile Idiopathic Arthritis-Related Uveitis 149
Vogt–Koyanagi–Harada patients show higher frequencies of circulating NKG2Dpos NK and NK T cells 148
Clinical Relevance of Subcentimetric Lymph Node Biopsy in the Diagnosis of Ocular Sarcoidosis 144
Corrigendum to: Increased expression of interleukin-22 in patients with giant cell arteritis 142
Efficacy of Rituximab Treatment in Vogt-Koyanagi-Harada Disease Poorly Controlled by Traditional Immunosuppressive Treatment 141
Eosinophilic giant cell arteritis: A different subset of disease? 141
Vitreoretinal lymphomas misdiagnosed as uveitis: Lessons learned from a case series 140
Interferon Alpha-2a Treatment for Post-Uveitic Refractory Macular Edema 139
Survival and Recurrence in Vitreoretinal Lymphoma Simulating Uveitis at Presentation: The Possible Role of Combined Chemotherapy 137
Role of miR-146a and miR-146b in Giant Cell Arteritis. 136
Fluorescein angiography findings in eyes with lamellar macular hole and epiretinal membrane foveoschisis 136
Insight into giant cell arteritis pathogenesis by NanoString nCounter gene expression profiling in temporal artery biopsies 134
Infantile-Onset Spinocerebellar Ataxia Type 5 (SCA5) with Optic Atrophy and Peripheral Neuropathy 133
Interleukin-6 promoter polymorphism at position -174 in giant cell arteritis 132
Genes deregulated in giant cell arteritis by Nanostring nCounter gene expression profiling in temporal artery biopsies 131
Uveitis in Tumor Patients Treated with Immunological Checkpoint- and Signal Transduction Pathway-Inhibitors 131
Bromfenac ophthalmic solution 0.09% as an adjunctive therapy to topical steroids after cataract surgery in pseudoexfoliation syndrome 130
Safety and Efficacy of Adalimumab in Patients with Noninfectious Uveitis in an Ongoing Open-Label Study: VISUAL III 128
Assessement and classification of choroidal vasculitis in intraocular inflammation using indocyanine green angiography 127
Aqueous tap and rapid diagnosis of cytomegalovirus anterior uveitis: the Reggio Emilia experience 125
Testo-atlante sulle Uveiti 125
Interleukin-6 expression in inflamed and non-inflamed temporal arteries from patients with giant cell arteritis 124
Twenty-four Month Outcomes in the Collaborative Ocular Tuberculosis Study (COTS)-1: Defining the "Cure" in Ocular Tuberculosis 121
Anterior Chamber Inflammation After Cataract Surgery: A Randomized Clinical Trial Comparing Bromfenac 0.09% to Dexamethasone 0.1% 120
The Collaborative Ocular Tuberculosis Study (COTS) Consensus (CON) Group Meeting Proceedings 120
Changes in patterns of uveitis at a tertiary referral center in Northern Italy: analysis of 990 consecutive cases 119
Beta-adrenergic antagonists in the treatment of glaucoma 116
Yag laser iridotomy in pigment dispersion syndrome: 10 years later 114
Visual Morbidity in Ocular Tuberculosis - Collaborative Ocular Tuberculosis Study (COTS)-1: Report #6 113
Effectiveness of Pegylated Interferon Alpha-2a in Post-Uveitic Macular Edema Previously Responding to Non-Pegylated Interferon 112
Ocular inflammatory events following COVID-19 vaccination: a multinational case series 112
Objective Quantification of Anterior Chamber Inflammation: Measuring Cells and Flare by Anterior Segment Optical Coherence Tomography 109
Totale 20.365
Salva come PNG Salva come JPEG
Categoria #
all - tutte 126.392
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 126.392
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202186 0 0 0 0 0 0 0 0 0 0 0 86
2021/20221.865 47 92 97 58 19 67 449 59 197 53 443 284
2022/20231.776 278 178 176 93 147 219 34 171 203 23 110 144
2023/20241.788 35 73 74 100 390 131 66 225 296 97 56 245
2024/20255.374 95 46 75 337 1.158 840 495 239 685 294 330 780
2025/202612.263 556 376 1.082 1.538 904 701 1.297 801 937 876 974 2.221
Totale 26.943